Some researchers even recommend discontinuing SGLT2 inhibitors perioperatively during PCI to reduce the incidence of AKI.[52] Therefore, there is ongoing debate regarding whether SGLT2 inhibitors are beneficial for AMI patients undergoing PCI. The gene discussed is SLC5A2; the disease is acute kidney injury.